Major Alzheimer's trial tests promising new pill to slow memory loss
Disease control
Ongoing
This large, late-stage study is testing whether a new oral medication called AR1001 can slow the progression of early Alzheimer's disease. Over 1,500 participants with mild memory problems will take either the drug or a placebo for one year. Researchers will measure changes in me…
Phase: PHASE3 • Sponsor: AriBio Co., Ltd. • Aim: Disease control
Last updated Mar 02, 2026 15:24 UTC